Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Hsien-Yi Chiu"'
Autor:
Ching-Chi Chi, Yen-Wen Wu, Ting-Hsing Chao, Chih-Chiang Chen, Yi-Ju Chen, Hao-Min Cheng, Hsien-Yi Chiu, Yu-Wei Chiu, Wen-Hung Chung, Tsu-Yi Hsieh, Po-Hsun Huang, Yu-Huei Huang, Shang-Hung Lin, Tsung-Hsien Lin, Kwo-Chang Ueng, Chun-Chieh Wang, Yu-Chen Wang, Nan-Lin Wu, Charles Jia-Yin Hou, Tsen-Fang Tsai
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 6, Pp 442-457 (2023)
Psoriatic disease is a chronic inflammatory disorder with skin and joint manifestations. Due to the persistent inflammatory state exhibited by patients with psoriasis, multiple systemic comorbidities occur more frequently in patients with psoriasis t
Externí odkaz:
https://doaj.org/article/264fe2239d8445d4b8467eb65f433f69
Autor:
Huai-Chia Chuang, Chia-Hsin Hsueh, Pu-Ming Hsu, Ching-Yi Tsai, Ying-Chun Shih, Hsien-Yi Chiu, Yi-Ming Chen, Wen-Kuang Yu, Ming-Han Chen, Tse-Hua Tan
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 21 (2023)
Dual-specificity phosphatase 8 (DUSP8) is a MAPK phosphatase that dephosphorylates and inactivates the kinase JNK. DUSP8 is highly expressed in T cells; however, the in vivo role of DUSP8 in T cells remains unclear. Using T cell–specific Dusp8 cond
Externí odkaz:
https://doaj.org/article/f37e99b47c2e42e8982271f79bee0148
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 14 (2023)
Background: Infection events are a major concern for patients and physicians when making psoriasis treatment decisions. Objective: To estimate the relative short-term risks of infection and serious infection for biologic and small molecule therapies
Externí odkaz:
https://doaj.org/article/14b4ad1c051c4aa69953752cfc7e10c1
Autor:
King-Jean Wu, Che-Chang Tu, Jia-Xuan Hu, Po-Han Chu, Kevin Sheng-Kai Ma, Hsien-Yi Chiu, Mark Yen-Ping Kuo, Tsen-Fang Tsai, Yi-Wen Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 10, Pp 1908-1916 (2022)
Background/purpose: Both psoriasis and periodontal diseases are characterized by an exaggerated immune response to the microbiota residing on epithelial surfaces. This study aimed to explore the associations between the severity of psoriasis and peri
Externí odkaz:
https://doaj.org/article/86b6556e292448eb8d4017444708e123
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 14 (2023)
Background: Patients with psoriasis have a significant disease burden throughout the life course. Nevertheless, the lifetime risk and disease burden of psoriasis across the entire lifespan is rarely quantified in an easily understandable way. Objecti
Externí odkaz:
https://doaj.org/article/c36557d9403b408e9e88c83aaf02a6e2
Autor:
Tsen-Fang Tsai, Tsu-Yi Hsieh, Ching-Chi Chi, Chung-Tei Chou, Lin-Fen Hsieh, Hsin-Hua Chen, Rosaline Chung-Yee Hui, Chih-Hung Lee, Chin-Hsiu Liu, Hwa-Chang Liu, Kai-Jieh Yeo, Chun-Hsiung Chen, Hung-An Chen, Ying-Chou Chen, Yi-Ju Chen, Hsien-Yi Chiu, Ji-Chen Ho, Yu-Huei Huang, Po-Ju Lai, Woan-Ruoh Lee, Hsien-Tzung Liao, Shang-Hung Lin, Jui-Cheng Tseng, Ting-Shun Wang, Nan-Lin Wu, Deng-Ho Yang, Wen-Chan Tsai, James Cheng-Chung Wei
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 3, Pp 926-938 (2021)
In Taiwan, the incidence and prevalence of psoriatic arthritis (PsA) have risen significantly in recent years. Moreover, data from the Taiwan National Health Insurance Research Database (NHIRD) show that more than 85% of PsA patients are treated with
Externí odkaz:
https://doaj.org/article/3920aaafa1d348799bf02fee570c6d2e
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Numerous previous studies have examined risk of herpes zoster (HZ) in psoriatic disease; however, the results of these studies are conflicting and the relative risks associated with different treatments remain largely unknown. In this met
Externí odkaz:
https://doaj.org/article/c468b46b71c0408499102ea5a48b238b
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Background: Real-life data on patients with psoriasis treated with guselkumab are few and are needed to compare with trial-based data. We investigated the effect of clinical factors on real-world effectiveness of guselkumab. Methods: This multicentre
Externí odkaz:
https://doaj.org/article/9111df0f504a43dea984a907e58b3302
Publikováno v:
PLoS ONE, Vol 16, Iss 12 (2021)
This study aimed to investigate the perceived threat, mental health outcomes, behavior changes, and associated predictors among psoriasis patients during the COVID-19 pandemic. The COVID-19 has been known to increase the health risks of patients with
Externí odkaz:
https://doaj.org/article/25dca7f5ab8342b98191f4cc0618533e
Publikováno v:
Dermatologica Sinica, Vol 36, Iss 3, Pp 115-123 (2018)
Psoriasis is a common, chronic immune-mediated disorder that occurs worldwide. The prevalence of psoriasis in Taiwan is lower than that in Caucasian countries. Nevertheless, an increasing trend in the prevalence of psoriasis and psoriatic arthritis h
Externí odkaz:
https://doaj.org/article/699ddf40d6fc4361884adae0caee5157